186 related articles for article (PubMed ID: 19299008)
1. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Lin YH; Chang CH; Wu YS; Hsu YM; Chiou SF; Chen YJ
Biomaterials; 2009 Jul; 30(19):3332-42. PubMed ID: 19299008
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo.
Luo D; Guo J; Wang F; Sun J; Li G; Cheng X; Chang M; Yan X
J Biomater Sci Polym Ed; 2009; 20(11):1587-96. PubMed ID: 19619399
[TBL] [Abstract][Full Text] [Related]
4. Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Ramteke S; Ganesh N; Bhattacharya S; Jain NK
J Drug Target; 2009 Apr; 17(3):225-34. PubMed ID: 19241256
[TBL] [Abstract][Full Text] [Related]
5. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
6. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
7. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice.
Aebischer T; Fischer A; Walduck A; Schlötelburg C; Lindig M; Schreiber S; Meyer TF; Bereswill S; Göbel UB
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):221-9. PubMed ID: 16487303
[TBL] [Abstract][Full Text] [Related]
8. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
[TBL] [Abstract][Full Text] [Related]
10. Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.
Chang CH; Huang WY; Lai CH; Hsu YM; Yao YH; Chen TY; Wu JY; Peng SF; Lin YH
Acta Biomater; 2011 Feb; 7(2):593-603. PubMed ID: 20813208
[TBL] [Abstract][Full Text] [Related]
11. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
Ishak RA; Awad GA; Mortada ND; Nour SA
J Control Release; 2007 Jun; 119(2):207-14. PubMed ID: 17412443
[TBL] [Abstract][Full Text] [Related]
12. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.
Yang JC; Shun CT; Chien CT; Wang TH
J Nutr; 2008 Nov; 138(11):2084-90. PubMed ID: 18936202
[TBL] [Abstract][Full Text] [Related]
13. Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
Lin YH; Lin JH; Chou SC; Chang SJ; Chung CC; Chen YS; Chang CH
Nanomedicine (Lond); 2015 Jan; 10(1):57-71. PubMed ID: 25177920
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-mediated and spatially selective electrodeposition of nanoscale particles.
Wu LQ; Lee K; Wang X; English DS; Losert W; Payne GF
Langmuir; 2005 Apr; 21(8):3641-6. PubMed ID: 15807614
[TBL] [Abstract][Full Text] [Related]
15. [Intensification of Helicobacter pylori colonization and serological markers of Helicobacter pylori infection and cytotoxicity in blood].
Bak-Romaniszyn L; Kałuzyński A; Chmiela M; Rudnicka W; Kulig A; Płaneta-Małecka I
Pol Merkur Lekarski; 2009 May; 26(155):407-11. PubMed ID: 19606685
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
[TBL] [Abstract][Full Text] [Related]
17. [How does Helicobacter pylori live in the stomach?].
Nakazawa T
Tanpakushitsu Kakusan Koso; 2001 Nov; 46(14):2025-33. PubMed ID: 11712331
[No Abstract] [Full Text] [Related]
18. Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.
Hejazi R; Amiji M
Int J Pharm; 2004 Mar; 272(1-2):99-108. PubMed ID: 15019073
[TBL] [Abstract][Full Text] [Related]
19. Antiadhesive property of microalgal polysaccharide extract on the binding of Helicobacter pylori to gastric mucin.
Loke MF; Lui SY; Ng BL; Gong M; Ho B
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):231-8. PubMed ID: 17521357
[TBL] [Abstract][Full Text] [Related]
20. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes.
Xu X; Capito RM; Spector M
J Biomed Mater Res A; 2008 Mar; 84(4):1038-48. PubMed ID: 17685397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
